UPDATE 1-Bristol-Myers profit tops Street view, raises full-year forecast
July 26, 2018 at 10:30 AM EDT
Bristol-Myers Squibb Co on Thursday reported better-than-expected second quarter earnings and raised its full-year forecast on strong sales of its blockbuster cancer drug Opdivo and blood thinner Eliquis.